As for what comes next, the signs aren’t promising. This Saturday (November 24th), Andre Berto will fight Robert Guerrero in Ontario, California, on a card promoted by Golden Boy.
Guerrero asked that the fighters be tested for PEDs by VADA. Walter Kane (Guerrero’s attorney) says that Richard Schaefer and Al Haymon (Berto’s manager) refused and would only allow testing by the California State Athletic Commission and USADA.
In other words, Berto said he’d do drug testing, but not with the people who caught him earlier this year.
Guerrero had two options. He could accept USADA and a career-high payday or lose the payday.
“I’m not happy about it,” Kane says, “but in the end, we really didn’t have a choice. Golden Boy controls the purse strings, and they’re calling the shots.”
Would the National Football League let Dallas Cowboys owner Jerry Jones dictate drug-testing terms for games the Cowboys play? Of course not. But in essence, Golden Boy (which has a vested interest in the outcome of the fights it promotes) is doing just that.
Once again, the playing field has been tilted. There are times when it appears as though, not only does Golden Boy dictate which drug-testing organization is utilized, it can also influence whether or not there is random blood and urine testing for a fight.
Indeed, Golden Boy might even be able to use its influence over the drug-testing process as a bargaining chip in signing fighters. Andre Berto tested positive and, soon after, was licensed to fight in California in a big-money fight. Erik Morales tested positive and New York said, “No problem. He can fight here right now.”
Meanwhile, Golden Boy is refusing to use a drug-testing agency that plays by the reporting rules (VADA) and is giving its business to an agency (USADA) that appears to have ceded a certain amount of reporting authority to the promoter.
The problems are overwhelming and there are no easy answers. Even state-of-the-art tests often fail to uncover PED use.
Olympic gold medalist Marion Jones was tested more than 160 times during her track-and-field career and none of the tests came back as a confirmed positive. As the BALCO investigation widened, she admitted she’d used steroids prior to the 2000 Olympics and lied to federal investigations about it. She pled guilty to federal charges and spent six months in prison. The tests have gotten more sophisticated since then, but so have the cheaters.
Should boxing even try to curtail PED use?
“Yes,” says Victor Conte. “There will always be athletes who escape detection, but when there’s a desperate need, half a loaf of bread is better than none.”
One might look to Major League Baseball for parallels. No sport wants to tarnish its image, let alone its major stars. But as baseball discovered, if a sport looks the other way, the use of PEDs can come back to haunt it.
Baseball got a huge bounce when Barry Bonds, Mark McGwire, and Sammy Sosa rewrote its record book. Now an entire era has been disgraced, and baseball’s most hallowed records (which link fans from one generation to the next) are in limbo.
Baseball made significant strides when it decided, finally, to crack down on PED use. Home run statistics are evidence of that. For eight consecutive seasons (between 1995 and 2002), the MLB home run leader hit at least 50 home runs. In the past five years, that mark has been reached only once. In the past two seasons, the four league leaders hit 44, 41, 43, and 39 home runs. Compare that with 1998, when Mark McGwire hit 70, Sammy Sosa hit 66, and Ken Griffey Jr. hit 56.
In boxing at present, the users are way ahead of the testers and the distance between them is growing. The only thing that can possibly close the gap is a national approach with uniform national standards and a uniform national enforcement mechanism. If additional federal legislation is necessary to achieve that end, so be it. The notion that boxing can clean itself up one state athletic commission at a time is frivolous.
To make real headway, it should be a condition for granting a license in any state that a fighter can be tested for PEDs at any time. Logistics and cost would make mandatory testing on a broad scale impractical, but unannounced spot testing could be implemented.